Wells Fargo’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wells Fargo's LLY Position: Q2 2026 in Review
Wells Fargo increased its Eli Lilly (LLY) stake by 5.5% in Q2 2026, buying an estimated $245M and bringing the position to 4,646,119 shares worth $5.57B. The position accounts for 0.9% of the portfolio, ranked #17.
Wells Fargo first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wells Fargo held 4,646,119 shares of Eli Lilly worth $5.57B as of Q2 2026.
- Wells Fargo bought 240,275 Eli Lilly shares in Q2 2026, an estimated $245M.
- Eli Lilly made up 0.9% of Wells Fargo's portfolio in Q2 2026, its #17 holding.
- Wells Fargo first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.